Telemark Hospital Trust Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Skien Norway (2002)

Organization Overview

First Clinical Trial
2004
NCT00360906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dep. of Neurology, Telemark Hospital | Sykehuset Telemark | Telemark Hospital Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Diseases (Phase 3)

Bronchiolitis (Phase 4)

Dementia (Phase 4)

Encephalitis (Phase 3)

Fatigue (Phase 4)

Fatigue Syndrome, Chronic (Phase 3)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Myalgia (Phase 3)

Nausea (Phase 4)

Sciatica (Phase 4)

Sclerosis (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 22